Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Canonical nuclear factor κB pathway links tumorigenesis of synchronous mantle-cell lymphoma, clear-cell renal-cell carcinoma, and GI stromal tumor.

× No keyword cloud information.

5 in total

1. Novel treatment for mantle cell lymphoma including therapy-resistant tumor by NF-κB and mTOR dual-targeting approach.

Authors: Nagendra K Chaturvedi; Rajkumar N Rajule; Ashima Shukla; Prakash Radhakrishnan; Gordon L Todd; Amarnath Natarajan; Julie M Vose; Shantaram S Joshi
Journal: Mol Cancer Ther Date: 2013-08-20 Impact factor: 6.261

2. Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families.

Authors: Janice P Dutcher; Peter H Wiernik; Leticia Varella; Rangaswamy Chintapatla
Journal: Fam Cancer Date: 2016-10 Impact factor: 2.375

3. Case Report: Clinical Responses to Tislelizumab as a First-Line Therapy for Primary Hepatocellular Carcinoma With B-Cell Indolent Lymphoma.

Authors: Qijun Li; Yong Dong; Yubin Pan; Honglin Tang; Da Li
Journal: Front Immunol Date: 2021-03-31 Impact factor: 7.561

4. A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma.

Authors: Faezeh Ajorloo; Mohammad Vaezi; Alireza Saadat; Seyed Reza Safaee; Behrouz Gharib; Mostafa Ghanei; Seyed Davar Siadat; Farzam Vaziri; Abolfazl Fateh; Mehrdad Pazhouhandeh; Behrouz Vaziri; Reza Moazemi; Fereidoun Mahboudi; Fatemeh Rahimi Jamnani
Journal: PLoS One Date: 2017-09-11 Impact factor: 3.240

5. [Synchronous lymphoma and carcinoma-clinical analyses of 17 patients].

Authors: Y Y Xiong; Z J Liu; L Chen; F F Yuan; Q S Yin; R H Mi; B Zhang; J W Du; Q L Zhang; Q D Lin; L N Zhang; X Gao; L H Dong; Y F Li; Y P Song; X D Wei
Journal: Zhonghua Xue Ye Xue Za Zhi Date: 2018-04-14

5 in total